FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

44411000001109: Dolmatil 200mg tablets (Sanofi-Synthelabo Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
16940901000001118 Dolmatil 200mg tablets (Sanofi-Synthelabo Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
65953801000001114 Dolmatil 200mg tablets (Sanofi) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dolmatil 200mg tablets (Sanofi-Synthelabo Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Dolmatil 200mg tablets (Sanofi-Synthelabo Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Dolmatil 200mg tablets (Sanofi-Synthelabo Ltd) Is a Product containing precisely sulpiride 200 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Dolmatil 200mg tablets (Sanofi-Synthelabo Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Dolmatil 200mg tablets (Sanofi-Synthelabo Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Dolmatil 200mg tablets (Sanofi-Synthelabo Ltd) Has active ingredient Sulpiride false Inferred relationship Existential restriction modifier
Dolmatil 200mg tablets (Sanofi-Synthelabo Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Dolmatil 200mg tablets (Sanofi-Synthelabo Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Dolmatil 200mg tablets (Sanofi-Synthelabo Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Dolmatil 200mg tablets (Sanofi-Synthelabo Ltd) Is a Dolmatil true Inferred relationship Existential restriction modifier
Dolmatil 200mg tablets (Sanofi-Synthelabo Ltd) Has specific active ingredient Sulpiride true Inferred relationship Existential restriction modifier
Dolmatil 200mg tablets (Sanofi-Synthelabo Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Dolmatil 200mg tablets (Sanofi-Synthelabo Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Dolmatil 200mg tablets (Sanofi-Synthelabo Ltd) 100 tablet 10 x 10 tablets Is pack of False Dolmatil 200mg tablets (Sanofi-Synthelabo Ltd) Inferred relationship Existential restriction modifier
Dolmatil 200mg tablets (Sanofi-Synthelabo Ltd) 100 tablet 10 x 10 tablets Has AMP True Dolmatil 200mg tablets (Sanofi-Synthelabo Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start